The Pharma Data

JANUARY 4, 2021

Chimeric PD-1 T-cells also release cytokines to further initiate immune responses to eradicate the tumor cells. is a preclinical stage biopharmaceutical company which is focused on discovering, developing, and commercializing novel immune-oncology applications through its robust product pipeline. Kiromic BioPharma, Inc.

Molecular Biology 40

Molecular Biology Therapies Immune Response Science 40

The Pharma Data

OCTOBER 14, 2020

(Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that the first participant was enrolled in the observational PRECISION study (TNX-C002), to examine the immune responses to COVID-19 in healthy volunteers who have recovered from COVID-19 or were asymptomatic.

Vaccine 40

Vaccine Pharmaceuticals Small Molecule Virus 40

BioPharma Drive: Drug Pricing

JUNE 27, 2025

These medicines are made from a patient’s own immune cells, extracted from the body and engineered in a lab to hunt down specific proteins found on the surface of malignant clones. For some people with leukemia, lymphoma or multiple myeloma, they can prompt powerful responses and even long-lasting remission.

Therapies 182

Therapies FDA Treatment Licensing 182

Codon

JUNE 5, 2025

The core of the CRISPR immune response is a guide RNA (gRNA) that binds to a CRISPR-associated (Cas) protein. Researchers have engineered more specific enzymes — possessing drastically reduced off-target effects — by altering either the structure of the Cas9 protein itself or its gRNA. Join Asimov Press.

DNA 78

DNA RNA Clinical Trials Engineering 78

Agency IQ

APRIL 12, 2024

The regulations also explain that this trait can be demonstrated via appropriate laboratory tests or adequately controlled clinical data. The International Society for Pharmaceutical Engineering (ISPE) took a more nuanced approach, requesting that the language be tweaked to indicate that multiple assays are often optional.

Production 40

Production FDA Therapies Biochemical Assays 40

Broad Institute

AUGUST 7, 2023

A surprising new role for a major immune regulator By Tom Ulrich August 7, 2023 Breadcrumb Home A surprising new role for a major immune regulator By Anne Trafton, MIT News August 7, 2023 Credit: RCSB Protein Data Bank A model of the human STING protein.

Regulations 91

Regulations Clinical Trials Engineering Science 91

DrugBank

MAY 6, 2024

Oral biologics offer a clever approach, using plant cells to encapsulate the drug, which helps reduce the immune system's production of unwanted antibodies, crucial for keeping gene therapy costs manageable. There's promising research ahead.

FDA Approval 96

FDA Approval Therapies Treatment Clinical Trials 96

Advarra

JANUARY 11, 2024

After injection of such a vaccine, the mRNA instructs cells to produce proteins designed to stimulate an immune response against these same protein targets when they show up in viruses or in tumor cells. Adoptive T Cell Therapies Adoptive T cell therapy is another form of cancer treatment leveraging the patient’s immune system.

Vaccine 52

Vaccine Therapies Clinical Trials Small Molecule 52

Drug Target Review

OCTOBER 10, 2024

In the context of preclinical research, using healthy cells to study disease-specific mechanisms, cell-cell interactions, and immune responses can result in faulty data, missed therapeutic targets, and unanticipated immune responses. Furthermore, fostering cross-industry collaboration is essential.

Therapies 52

Therapies Immune Response Clinical Trials Disease 52

Codon

FEBRUARY 13, 2024

Regulators traditionally want to see a single, stable, well-characterized drug before giving the green light for it to be tested in a clinical trial, not dozens of different viruses; let alone ones that are best found in unappealing places like sewage , hospital waste, or bird poop. aeruginosa, S. aureus, and K. pneumoniae.

Therapies 136

Therapies Virus DNA Clinical Trials 136

Codon

APRIL 2, 2024

A gene encoding green fluorescent protein was placed alongside one of the three promoters, and as the engineered cells cycled from one gene to the next, they blinked between green—dark—green—dark. Elowitz had created cells that acted as living oscillators. Subscribe to receive future essays from Asimov Press.

RNA 57

RNA Engineering Molecular Biology Synthetic Chemistry 57

DrugBank

FEBRUARY 26, 2025

Quorum sensing , a process by which bacteria communicate to regulate group behaviors, is one promising target. This system enables bacteria to coordinate activities such as biofilm formation, which provides protection from antibiotics and the immune system.

Therapies 52

Therapies Pharmaceutical Companies Pharmacokinetics Treatment 52

Codon

APRIL 23, 2023

Unfortunately, they can also trigger immune responses, and they are not super efficient at gene-editing some parts of the brain. These ribonucleoproteins also caused a lower immune response compared to the viruses, and are much easier to make in the lab. in Nature Biomedical Engineering. Ming Li et al. in bioRxiv.

Vaccine 52

Vaccine DNA Virus Engineering 52

Codon

APRIL 23, 2023

Unfortunately, they can also trigger immune responses, and they are not super efficient at gene-editing some parts of the brain. These ribonucleoproteins also caused a lower immune response compared to the viruses, and are much easier to make in the lab. in Nature Biomedical Engineering. Ming Li et al. in bioRxiv.

Vaccine 52

Vaccine DNA Virus Engineering 52

Codon

APRIL 30, 2023

Read more at Nature Biotechnology ( Similar paper at Nature Biomedical Engineering.) But now, their engineered brethren can live about 82 percent longer. Often, when we engineer a cell, we only mess with the magnitude of an effect; this study suggests that we should think more about the timing, too. From Zhang et al.

Vaccine 52

Vaccine DNA Engineering RNA 52

Codon

APRIL 30, 2023

Read more at Nature Biotechnology ( Similar paper at Nature Biomedical Engineering.) But now, their engineered brethren can live about 82 percent longer. Often, when we engineer a cell, we only mess with the magnitude of an effect; this study suggests that we should think more about the timing, too. From Zhang et al.

Vaccine 52

Vaccine DNA Engineering RNA 52

LifeSciVC

MAY 9, 2024

Take Janux Therapeutics, a biotech focused on developing immunotherapies that generate tumor-specific immune responses to attack and kill tumors without destroying a patient’s healthy tissue. While early, these data demonstrate clear promise to advance this modality.

Immune Response 87

Immune Response Vaccine Therapies Clinical Development 87

Codon

JULY 27, 2023

But for a recent paper out of Nanjing, China, researchers engineered another enzyme and showed that, when mixed with FAST-PETase, the two worked together to break down plastic twice as fast as the Texas enzyme alone. These protein:RNA duos seem to regulate gene expression in a way that we don’t really understand. No longer.

Therapies 52

Therapies RNA DNA Engineering 52

Codon

JULY 27, 2023

But for a recent paper out of Nanjing, China, researchers engineered another enzyme and showed that, when mixed with FAST-PETase, the two worked together to break down plastic twice as fast as the Texas enzyme alone. These protein:RNA duos seem to regulate gene expression in a way that we don’t really understand. No longer.

Therapies 52

Therapies RNA DNA Engineering 52

Codon

APRIL 9, 2023

LanzaTech announced a partnership with H&M Move to convert factory carbon emissions into fabrics using engineered microbes. Sponge cells double in population quite quickly — around 40 minutes — and could be engineered to manufacture drugs. Read Biological Engineering *Self-healable spider dragline silk materials.

Therapies 52

Therapies RNA Engineering Vaccine 52

The Pharma Data

AUGUST 3, 2021

whose proprietary peptide- and protein-engineering platform is used to identify and synthesize molecules that can sense glucose or other endogenous modulators of protein activity. The company announced the acquisition of Protomer Technologies Inc., Loxo Oncology at Lilly and Kumquat Biosciences Inc.

Production 52

Production Marketing Research Government 52

Codon

JULY 14, 2024

In 1940, Charles Drew—the first African-American researcher to earn a doctor of medical science degree at Columbia University—developed an ingenious method for separating and storing plasma , the liquid part of blood that contains essential proteins that promote clotting and regulate blood pressure.

Production 143

Production Clinical Trials Trials Therapies 143

Drug Target Review

DECEMBER 13, 2024

Engineering sites on the antibody to enable specific and consistent attachment of the cytotoxic drug to achieve an optimal drug-to-antibody ratio (DAR).

Therapies 98

Therapies Treatment Clinical Trials Drugs 98

Codon

APRIL 16, 2023

Codon Digest is my weekly roundup of research, news, and industry highlights about engineered biology. Skin microbes can trigger strong immune responses. In other words: Brush some engineered bacteria on the skin, and they activate the immune system to go fight a tumor. Please send me your feedback. Cell Reports.

Engineering 52

Engineering DNA RNA Science 52

Codon

DECEMBER 12, 2024

As Richard Dawkins said of biological wheels : “the engineering solution can be seen in plain view, yet [it is] unattainable in evolution because it lies [on] the other side of a deep valley.” ” 19 There are some exceptions, though such MAMPs may not be sufficient on their own to trigger sufficient immune responses.

RNA 104

RNA DNA Vaccine Virus 104

Drug Target Review

DECEMBER 12, 2024

Aside from the ethical questions they raise, ESCs are in limited supply and are generally recognised as foreign by the recipient patients immune system. This can trigger an immune response that causes the body to reject these therapeutic cells.

Therapies 59

Therapies DNA Molecular Biology Immune Response 59

The Pharma Data

SEPTEMBER 8, 2020

Both vaccine candidates incorporate Novavax’ proprietary saponin-based Matrix-M adjuvant in order to enhance the immune response and stimulate high levels of neutralizing antibodies. A further list and descriptions of these risks, uncertainties and other factors can be found in. the United States.

Science 52

Science Vaccine Clinical Trials Pharmaceutical Companies 52

The Pharma Data

SEPTEMBER 8, 2020

Both vaccine candidates incorporate Novavax’ proprietary saponin-based Matrix-M adjuvant in order to enhance the immune response and stimulate high levels of neutralizing antibodies.

Science 52

Science Vaccine Clinical Trials Pharmaceutical Companies 52

Drug Target Review

MAY 8, 2025

While reducing mutant huntingtin is desirable, the wild-type huntingtin protein plays crucial roles in normal neuronal function, including vesicular transport, synaptic function and transcriptional regulation. Thus complete suppression of all huntingtin protein could potentially create new problems despite addressing the original disease.

Disease 111

Disease Treatment DNA Therapies 111

SugarCone Biotech

MAY 28, 2019

Those approvals also are the basis of extensive efforts to produce less toxic variants of IL-2 by engineering selective IL-2 receptor engagement, as exemplified by the drug development work of Nektar, Alkermes, Roche and many others. The immune system is tightly regulated and unkind to inappropriate signals. T cell engagers.

Immune Response 52

Immune Response Therapies Engineering Drug Development 52

Codon

MARCH 26, 2023

Link Biological Engineering *Photosynthesis re-wired on the pico-second timescale. Link A Genetic Programming Approach to Engineering MRI Reporter Genes. Link Genetically encoded, noise-tolerant, auxin biosensors in yeast facilitate metabolic engineering and directed evolution. Metabolic Engineering. Antika T.R.

DNA 52

DNA Engineering RNA Science 52